Skip to main content
. 2022 Dec 15;18(7):2153533. doi: 10.1080/21645515.2022.2153533

Table 1.

General characteristics and hepatitis B viral infection outcomes by dose of hepatitis B vaccine.

General characteristics or outcomes Dose of hepatitis B vaccine
P value
5μg (N = 919) 10μg (N = 891) Unknown (N = 210)
No. (%) No. (%) No. (%)
Urban residents 373 (40.6) 360 (40.4) 75 (35.7) .41
Birth year       <.001
  <2002 144 (15.7) 8 (0.9) 176 (83.8)  
≥2002 775 (84.3) 883 (99.1) 34 (16.2)  
Male 467 (50.8) 463 (52.0) 106 (50.5) .86
Han ethnicity 911 (99.1) 878 (98.5) 208 (99.0) .48
Birth place       <.001
  Hospital 807 (87.8) 882 (99.0) 46 (21.9)  
Home 6 (0.7) 8 (0.9) 0 (0)  
Unknown 106 (11.5) 1 (0.1) 164 (78.1)  
Mother’s HBsAg       <.001
  Negative 478 (52.0) 613 (68.8) 26 (12.4)  
Positive 61 (6.6) 82 (9.2) 3 (1.4)  
Unknown 380 (41.3) 196 (22.0) 181 (86.2)  
HBV infection 35 (3.8) 5 (0.6) 109 (51.9) <.001
HBsAg carrier 9 (1.0) 2 (0.2) 14 (6.7) <.001
Anti-HBc positive 35 (3.8) 5 (0.6) 86 (35.5) <.001